Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Tenaya Therapeutics Inc.

    NASDAQ: TNYA · Real-Time Price · USD
    0.62
    -0.00 (-0.37%)
    At close: Jun 17, 2025, 10:23 AM

    Tenaya Therapeutics Statistics

    Share Statistics

    Tenaya Therapeutics has 162.67M shares outstanding. The number of shares has increased by 107.07% in one year.

    Shares Outstanding

    n/a
    		 162.67M

    Shares Change (YoY)

    n/a
    		 107.07%

    Shares Change (QoQ)

    n/a
    		 105.23%

    Owned by Institutions (%)

    n/a
    		 50.7%

    Shares Floating

    n/a
    		 134.18M

    Failed to Deliver (FTD) Shares

    n/a
    		 496

    FTD / Avg. Volume

    n/a
    		 0.02%

    Short Selling Information

    The latest short interest is 12.05M, so 7.41% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 12.05M

    Short % of Shares Out

    n/a
    		 7.41%

    Short % of Float

    n/a
    		 20.41%

    Short Ratio (days to cover)

    n/a
    		 6.45

    Valuation Ratios

    The PE ratio is -1.09 and the forward PE ratio is -0.83. Tenaya Therapeutics's PEG ratio is 0.05.

    PE Ratio

    n/a
    		 -1.09

    Forward PE

    n/a
    		 -0.83

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.1

    PB Ratio

    n/a
    		 1.31

    P/FCF Ratio

    n/a
    		 -1.33

    PEG Ratio

    n/a
    		 0.05
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Tenaya Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 4.22, with a Debt / Equity ratio of 0.15.

    Current Ratio

    n/a
    		 4.22

    Quick Ratio

    n/a
    		 4.22

    Debt / Equity

    n/a
    		 0.15

    Debt / EBITDA

    n/a
    		 -0.13

    Debt / FCF

    n/a
    		 -0.15

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,145,659.79

    Employee Count

    n/a
    		 97

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -81.21% in the last 52 weeks. The beta is 2.92, so Tenaya Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.92

    52-Week Price Change

    n/a
    		 -81.21%

    50-Day Moving Average

    n/a
    		 0.49

    200-Day Moving Average

    n/a
    		 1.4

    Relative Strength Index (RSI)

    n/a
    		 61.99

    Average Volume (20 Days)

    n/a
    		 2,467,973

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -115.95M

    Net Income

    n/a
    		 -111.13M

    EBITDA

    n/a
    		 -102.66M

    EBIT

    n/a
    		 -111.13M

    Earnings Per Share (EPS)

    n/a
    		 -1.31
    Full Income Statement

    Balance Sheet

    The company has 4.32M in cash and 13.61M in debt, giving a net cash position of -9.29M.

    Cash & Cash Equivalents

    n/a
    		 4.32M

    Total Debt

    n/a
    		 13.61M

    Net Cash

    n/a
    		 -9.29M

    Retained Earnings

    n/a
    		 -514.41M

    Total Assets

    n/a
    		 143.95M

    Working Capital

    n/a
    		 80.33M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -90.5M and capital expenditures -1.02M, giving a free cash flow of -91.53M.

    Operating Cash Flow

    n/a
    		 -90.5M

    Capital Expenditures

    n/a
    		 -1.02M

    Free Cash Flow

    n/a
    		 -91.53M

    FCF Per Share

    n/a
    		 -1.08
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    TNYA does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for TNYA is $5.5, which is 787.1% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $5.5

    Price Target Difference

    n/a
    		 787.1%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 4
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -5.34

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist